Does the media favor LFST or LMRI?

In the previous week, LifeStance Health Group had 5 more articles in the media than Lumexa Imaging. MarketBeat recorded 6 mentions for LifeStance Health Group and 1 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.34 beat LifeStance Health Group's score of 0.37 indicating that Lumexa Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lumexa Imaging 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to LMRI or CON?

In the previous week, Concentra Group Holdings Parent had 7 more articles in the media than Lumexa Imaging. MarketBeat recorded 8 mentions for Concentra Group Holdings Parent and 1 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.34 beat Concentra Group Holdings Parent's score of 0.66 indicating that Lumexa Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Concentra Group Holdings Parent 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor LMRI or OPCH?

In the previous week, Option Care Health had 4 more articles in the media than Lumexa Imaging. MarketBeat recorded 5 mentions for Option Care Health and 1 mentions for Lumexa Imaging. Option Care Health's average media sentiment score of 1.35 beat Lumexa Imaging's score of 1.34 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Option Care Health 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor LMRI or PRVA?

In the previous week, Privia Health Group had 11 more articles in the media than Lumexa Imaging. MarketBeat recorded 12 mentions for Privia Health Group and 1 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.34 beat Privia Health Group's score of 0.50 indicating that Lumexa Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Privia Health Group 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, HTFL or LMRI?

Lumexa Imaging has higher revenue and earnings than Heartflow. Lumexa Imaging is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 13.37 -$116.79M -$3.11 N/A Lumexa Imaging $267.73M 4.41 -$47.10M -$0.59 N/A

Is HTFL or LMRI more profitable?

Lumexa Imaging has a net margin of 0.00% compared to Heartflow's net margin of -58.42%. Company Net Margins Return on Equity Return on Assets Heartflow -58.42% N/A -20.02% Lumexa Imaging N/A N/A N/A

Does the media refer more to HTFL or LMRI?

In the previous week, Heartflow had 3 more articles in the media than Lumexa Imaging. MarketBeat recorded 4 mentions for Heartflow and 1 mentions for Lumexa Imaging. Heartflow's average media sentiment score of 1.45 beat Lumexa Imaging's score of 1.34 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lumexa Imaging 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Lumexa Imaging (LMRI) Competitors

$12.29 -0.41 (-3.23%)

Closing price 04:00 PM Eastern

Extended Trading

$12.28 -0.01 (-0.12%)

As of 04:10 PM Eastern

Compare

LMRI vs. LFST, CON, OPCH, PRVA, and HTFL

Should you buy Lumexa Imaging stock or one of its competitors? MarketBeat compares Lumexa Imaging with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Lumexa Imaging include LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), Option Care Health (OPCH), Privia Health Group (PRVA), and Heartflow (HTFL). These companies are all part of the "healthcare" industry.

How does Lumexa Imaging compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, media sentiment, risk, dividends and earnings.

LifeStance Health Group has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	2.97	$9.66M	$0.06	181.67
Lumexa Imaging	$267.73M	4.41	-$47.10M	-$0.59	N/A

LifeStance Health Group presently has a consensus target price of $9.75, suggesting a potential downside of 10.55%. Lumexa Imaging has a consensus target price of $16.00, suggesting a potential upside of 30.19%. Given Lumexa Imaging's higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.91
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, LifeStance Health Group had 5 more articles in the media than Lumexa Imaging. MarketBeat recorded 6 mentions for LifeStance Health Group and 1 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.34 beat LifeStance Health Group's score of 0.37 indicating that Lumexa Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lumexa Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

85.5% of LifeStance Health Group shares are held by institutional investors. 6.6% of LifeStance Health Group shares are held by insiders. Comparatively, 0.7% of Lumexa Imaging shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

LifeStance Health Group has a net margin of 1.55% compared to Lumexa Imaging's net margin of 0.00%. LifeStance Health Group's return on equity of 1.56% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	1.55%	1.56%	1.07%
Lumexa Imaging	N/A	N/A	N/A

Summary

LifeStance Health Group beats Lumexa Imaging on 13 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to Concentra Group Holdings Parent?

Lumexa Imaging (NASDAQ:LMRI) and Concentra Group Holdings Parent (NYSE:CON) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

Concentra Group Holdings Parent has a net margin of 7.97% compared to Lumexa Imaging's net margin of 0.00%. Concentra Group Holdings Parent's return on equity of 47.14% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
Concentra Group Holdings Parent	7.97%	47.14%	6.48%

Lumexa Imaging currently has a consensus target price of $16.00, suggesting a potential upside of 30.19%. Concentra Group Holdings Parent has a consensus target price of $30.20, suggesting a potential downside of 4.68%. Given Lumexa Imaging's higher probable upside, equities research analysts plainly believe Lumexa Imaging is more favorable than Concentra Group Holdings Parent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Concentra Group Holdings Parent	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

In the previous week, Concentra Group Holdings Parent had 7 more articles in the media than Lumexa Imaging. MarketBeat recorded 8 mentions for Concentra Group Holdings Parent and 1 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.34 beat Concentra Group Holdings Parent's score of 0.66 indicating that Lumexa Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Concentra Group Holdings Parent	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Concentra Group Holdings Parent has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	4.41	-$47.10M	-$0.59	N/A
Concentra Group Holdings Parent	$2.16B	1.87	$166.41M	$1.39	22.79

Summary

Concentra Group Holdings Parent beats Lumexa Imaging on 10 of the 14 factors compared between the two stocks.

How does Lumexa Imaging compare to Option Care Health?

Lumexa Imaging (NASDAQ:LMRI) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

Option Care Health has a net margin of 3.64% compared to Lumexa Imaging's net margin of 0.00%. Option Care Health's return on equity of 18.17% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
Option Care Health	3.64%	18.17%	7.16%

In the previous week, Option Care Health had 4 more articles in the media than Lumexa Imaging. MarketBeat recorded 5 mentions for Option Care Health and 1 mentions for Lumexa Imaging. Option Care Health's average media sentiment score of 1.35 beat Lumexa Imaging's score of 1.34 indicating that Option Care Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Option Care Health	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Option Care Health has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	4.41	-$47.10M	-$0.59	N/A
Option Care Health	$5.65B	0.60	$207.59M	$1.29	16.72

Lumexa Imaging presently has a consensus price target of $16.00, suggesting a potential upside of 30.19%. Option Care Health has a consensus price target of $30.54, suggesting a potential upside of 41.58%. Given Option Care Health's higher probable upside, analysts clearly believe Option Care Health is more favorable than Lumexa Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Option Care Health	1 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.64

98.1% of Option Care Health shares are held by institutional investors. 0.7% of Lumexa Imaging shares are held by insiders. Comparatively, 1.7% of Option Care Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Option Care Health beats Lumexa Imaging on 13 of the 15 factors compared between the two stocks.

How does Lumexa Imaging compare to Privia Health Group?

Lumexa Imaging (NASDAQ:LMRI) and Privia Health Group (NASDAQ:PRVA) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

Lumexa Imaging presently has a consensus target price of $16.00, indicating a potential upside of 30.19%. Privia Health Group has a consensus target price of $31.15, indicating a potential upside of 14.41%. Given Lumexa Imaging's higher possible upside, equities analysts plainly believe Lumexa Imaging is more favorable than Privia Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Privia Health Group has a net margin of 0.97% compared to Lumexa Imaging's net margin of 0.00%. Privia Health Group's return on equity of 2.81% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
Privia Health Group	0.97%	2.81%	1.61%

In the previous week, Privia Health Group had 11 more articles in the media than Lumexa Imaging. MarketBeat recorded 12 mentions for Privia Health Group and 1 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.34 beat Privia Health Group's score of 0.50 indicating that Lumexa Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

94.5% of Privia Health Group shares are owned by institutional investors. 0.7% of Lumexa Imaging shares are owned by company insiders. Comparatively, 5.7% of Privia Health Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Privia Health Group has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	4.41	-$47.10M	-$0.59	N/A
Privia Health Group	$2.12B	1.62	$22.92M	$0.16	170.19

Summary

Privia Health Group beats Lumexa Imaging on 12 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to Heartflow?

Heartflow (NASDAQ:HTFL) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

Heartflow currently has a consensus price target of $37.00, suggesting a potential upside of 35.58%. Lumexa Imaging has a consensus price target of $16.00, suggesting a potential upside of 30.19%. Given Heartflow's stronger consensus rating and higher possible upside, equities research analysts clearly believe Heartflow is more favorable than Lumexa Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.70
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Heartflow had 3 more articles in the media than Lumexa Imaging. MarketBeat recorded 4 mentions for Heartflow and 1 mentions for Lumexa Imaging. Heartflow's average media sentiment score of 1.45 beat Lumexa Imaging's score of 1.34 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lumexa Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lumexa Imaging has a net margin of 0.00% compared to Heartflow's net margin of -58.42%.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
Lumexa Imaging	N/A	N/A	N/A

Lumexa Imaging has higher revenue and earnings than Heartflow. Lumexa Imaging is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	13.37	-$116.79M	-$3.11	N/A
Lumexa Imaging	$267.73M	4.41	-$47.10M	-$0.59	N/A

Summary

Heartflow beats Lumexa Imaging on 7 of the 12 factors compared between the two stocks.

Get Lumexa Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMRI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LMRI vs. The Competition

Export

Metric	Lumexa Imaging	Services – Health Industry	Services Sector	NASDAQ Exchange
Market Cap	$1.18B	$2.01B	$22.75B	$12.44B
Dividend Yield	N/A	N/A	5.23%	6.52%
P/E Ratio	-20.83	24.41	18.83	24.45
Price / Sales	4.41	20.91	38.80	95.17
Price / Cash	35.75	105.95	57.86	49.26
Price / Book	1.98	29.86	12.32	6.42
Net Income	-$47.10M	-$30.36M	-$15.27M	$335.85M
7 Day Performance	8.95%	1.94%	-0.44%	-0.48%
1 Month Performance	44.59%	10.84%	4.89%	3.38%
1 Year Performance	N/A	N/A	-21.76%	24.97%

Lumexa Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LMRI Lumexa Imaging	4.6293 of 5 stars	$12.29 -3.2%	$16.00 +30.2%	N/A	$1.18B	$267.73M	N/A	5,019
LFST LifeStance Health Group	3.188 of 5 stars	$9.88 +2.4%	$9.75 -1.3%	+130.8%	$3.74B	$1.42B	164.67	10,961	Analyst Upgrade
CON Concentra Group Holdings Parent	3.9394 of 5 stars	$29.51 +1.3%	$30.20 +2.3%	+54.8%	$3.73B	$2.23B	21.23	13,133	News Coverage Insider Trade
OPCH Option Care Health	4.8261 of 5 stars	$21.48 -2.4%	$30.54 +42.2%	-29.0%	$3.46B	$5.65B	16.65	8,266	Positive News
PRVA Privia Health Group	4.1491 of 5 stars	$24.53 +0.1%	$31.15 +27.0%	+23.0%	$3.09B	$2.12B	153.32	1,226

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LMRI) was last updated on 7/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lumexa Imaging (LMRI) Competitors

LMRI vs. LFST, CON, OPCH, PRVA, and HTFL

How does Lumexa Imaging compare to LifeStance Health Group?

Summary

How does Lumexa Imaging compare to Concentra Group Holdings Parent?

Summary

How does Lumexa Imaging compare to Option Care Health?

Summary

How does Lumexa Imaging compare to Privia Health Group?

Summary

How does Lumexa Imaging compare to Heartflow?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lumexa Imaging (LMRI) Competitors

LMRI vs. LFST, CON, OPCH, PRVA, and HTFL

How does Lumexa Imaging compare to LifeStance Health Group?

Which has higher valuation and earnings, LFST or LMRI?

Do analysts prefer LFST or LMRI?

Does the media favor LFST or LMRI?

Do institutionals and insiders believe in LFST or LMRI?

Is LFST or LMRI more profitable?

Summary

How does Lumexa Imaging compare to Concentra Group Holdings Parent?

Is LMRI or CON more profitable?

Do analysts recommend LMRI or CON?

Does the media refer more to LMRI or CON?

Which has stronger earnings & valuation, LMRI or CON?

Summary

How does Lumexa Imaging compare to Option Care Health?

Is LMRI or OPCH more profitable?

Does the media favor LMRI or OPCH?

Which has better earnings and valuation, LMRI or OPCH?

Do analysts rate LMRI or OPCH?

Do institutionals & insiders believe in LMRI or OPCH?

Summary

How does Lumexa Imaging compare to Privia Health Group?

Do analysts prefer LMRI or PRVA?

Is LMRI or PRVA more profitable?

Does the media favor LMRI or PRVA?

Do institutionals and insiders believe in LMRI or PRVA?

Which has higher earnings & valuation, LMRI or PRVA?

Summary

How does Lumexa Imaging compare to Heartflow?

Do analysts prefer HTFL or LMRI?

Does the media refer more to HTFL or LMRI?

Is HTFL or LMRI more profitable?

Which has stronger earnings and valuation, HTFL or LMRI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools